Sign in

Toszka Bohn

@toszkabohn.bsky.social
31 followers 48 following 4 posts

Group Leader in Mainz, Interested in Tumor Immunology, Tumor Acidosis and Immunotherapy

PostsRepliesMedia
Reposted by Toszka Bohn
Signal Transduction and Targeted Therapy @sigtrans-sttt.bsky.social · 11/07/2026
How do tumors promote immune suppression? This study identifies proton-sensing GPR65 as a regulator of the immunosuppressive #TumorMicroenvironment, highlighting a promising target for #Cancer #Immunotherapy. @unimainz.bsky.social #STTT #OpenAccess: doi.org/10.1038/s413...
Solid tumors exploit proton-sensing GPR65 for orchestration of an immunosuppressive tumor microenvironment
021
Toszka Bohn @toszkabohn.bsky.social · 20/05/2026
Check out our latest publication.
000
Toszka Bohn @toszkabohn.bsky.social · 15/05/2026
How do pH-sensing tumor-associated macrophages shape the tumor microenvironment and how do they contribute to the progression of strongly acidic tumors? Check it out here: www.nature.com/articles/s41... Thanks to all people who contributed to this work! @sigtrans-sttt.bsky.social
nature.com
Solid tumors exploit proton-sensing GPR65 for orchestration of an immunosuppressive tumor microenvironment - Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy - Solid tumors exploit proton-sensing GPR65 for orchestration of an immunosuppressive tumor microenvironment
000
Reposted by Toszka Bohn
Nature @nature.com · 20/01/2026
Nature research paper: Ligand-specific activation trajectories dictate GPCR signalling in cells go.nature.com/45R1og5
go.nature.com
Ligand-specific activation trajectories dictate GPCR signalling in cells - Nature
Different agonists produce equilibria of at least four distinct active states of the G-protein-bound M2 muscarinic acetylcholine receptor, each with a different ability to activate G proteins.
092
Reposted by Toszka Bohn
Johannes Gutenberg-Universität Mainz @unimainz.bsky.social · 15/01/2026
Großer Forschungserfolg der #UnimedizinMainz zur Rezeptoraktivierung in lebenden Zellen: Pharmakologe Andreas Bock entwickelt Biosensoren, die Strukturänderungen von Rezeptoren in Echtzeit sichtbar machen 👉 www.unimedizin-mainz.de/newsroom/neui… #Pharmakologie
031
Reposted by Toszka Bohn
Deutsche Forschungsgemeinschaft @dfg.de · 21/11/2025
Die #DFG fördert zur weiteren Stärkung der #Spitzenforschung an den Hochschulen 9 neue #Sonderforschungsbereiche (SFB). Die Themen reichen von pilzbasierten Baumaterialien über Autoimmunkrankheiten bis zu molekularer Bor-Chemie. Einzelheiten 👉 www.dfg.de/de/service/p...
Die DFG richtet 9 neue Sonderforschungsbereiche ein, mit einer Förderung von 120 Mio. Euro für die erste Förderperiode. Ein neuer Verbund ist SFB/Transregio (TRR), getragen von mehreren Hochschulen. 32 Sonderforschungsbereiche, darunter 15 SFB/Transregio, werden verlängert.
1318
Reposted by Toszka Bohn
Katrin Pape @katrinpape.bsky.social · 26/08/2025
Excited to see our paper on the CD5 signalling pathway in Th17 cells and its role in #MultipleSclerosis out in @brain1878.bsky.social today. Thanks to everyone involved in this great team work! @neurologymainz.bsky.social @toszkabohn.bsky.social #ImmunoSky academic.oup.com/brain/advanc...
academic.oup.com
Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis
Pape et al. link the CD5-CK2-STAT3 signalling pathway to both inflammation and effector function in multiple sclerosis, using a multi-modal approach that c
163